RYAN HORNUNG: Open Payments
NPI 1497153985 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,048 in 225 payments from 35 companies in 2025. Trend: 2023 $3,663 · 2024 $3,381 · 2025 $4,048
Food & beverage: $4,048
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 29 | $462 |
| AstraZeneca Pharmaceuticals LP | 17 | $436 |
| ABBVIE INC. | 26 | $425 |
| GlaxoSmithKline, LLC. | 21 | $315 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $240 |
| Lilly USA, LLC | 13 | $233 |
| PFIZER INC. | 20 | $227 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $226 |
| Axsome Therapeutics, Inc. | 9 | $170 |
| Dexcom, Inc. | 6 | $137 |
Products named: JARDIANCE, TRELEGY ELLIPTA, CAPLYTA, VRAYLAR, Wegovy, BREZTRI, MOUNJARO, Ozempic.
Industry payments across PA — which companies pay providers there.
